See more : Entrée Resources Ltd. (ETG.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Link Reservations Inc. (LRSV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Link Reservations Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- sindoh Co.,Ltd. (029530.KS) Income Statement Analysis – Financial Results
- New Tmw Topco Inc. (NWTM) Income Statement Analysis – Financial Results
- HPSP Co., Ltd. (403870.KQ) Income Statement Analysis – Financial Results
- T&S inc. (4055.T) Income Statement Analysis – Financial Results
- Otsuka Holdings Co., Ltd. (4578.T) Income Statement Analysis – Financial Results
Link Reservations Inc. (LRSV)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.linkreservationsinc.com
About Link Reservations Inc.
Link Reservations Inc. develops and markets medicinal mushroom and cannabidiol wellness products for humans and pets in Europe and the United States. It offers hemp-based CBD products for cats, dogs, and horses, as well as for humans. The company was formerly known as Vendum Batteries, Inc. and changed its name to Link Reservations Inc. in May 2015. Link Reservations Inc. was incorporated in 2006 and is based in Kington, the United Kingdom.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 18.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 18.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 523.71K | 328.53K | 26.96K | 37.40K | 25.90K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | -223.35K | 0.00 | 237.82K | 94.46K | 19.44K | 20.19K | 24.57K | 36.94K | 523.71K | 328.53K | 26.96K | 37.40K | 25.90K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -505.41K | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | -223.35K | 0.00 | 237.82K | 94.46K | 19.44K | 20.19K | 24.57K | 36.94K | 523.71K | 328.53K | 27.61K | 51.00K | 26.28K |
Cost & Expenses | -223.35K | 0.00 | 237.82K | 94.46K | 19.44K | 20.19K | 24.57K | 36.94K | 523.71K | 328.53K | 27.61K | 51.00K | 26.28K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 11.86K | 0.00 | 1.62K | 1.62K | 0.00 | 0.00 | 101.73K | 6.84K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 386.00 | 386.00 | 385.00 |
EBITDA | 5.13K | 136.23K | -219.76K | -95.24K | -19.44K | -4.50K | -24.57K | -36.94K | -677.80K | -628.53K | -27.22K | -50.62K | -25.90K |
EBITDA Ratio | 0.00% | 0.00% | -1,216.97% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -223.35K | 0.00 | -219.76K | -94.46K | -19.44K | -20.19K | -24.57K | -36.94K | -523.71K | -328.53K | -27.61K | -51.00K | -26.28K |
Operating Income Ratio | 0.00% | 0.00% | -1,216.97% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 212.90K | 0.00 | -11.86K | -779.00 | -1.62K | 14.07K | 0.00 | -2.00 | -255.81K | -306.84K | 0.00 | 0.00 | 0.00 |
Income Before Tax | -10.45K | 0.00 | -231.62K | -95.24K | -21.06K | -6.12K | -24.57K | -36.94K | -779.52K | -635.38K | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | 0.00% | 0.00% | -1,282.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -223.35K | 0.00 | -206.30K | -171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -10.45K | 0.00 | -231.62K | -95.24K | -21.06K | -6.12K | -24.57K | -36.94K | -779.52K | -635.38K | -27.61K | -51.00K | -26.28K |
Net Income Ratio | 0.00% | 0.00% | -1,282.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 790.10M | 0.00 | 375.50M | 220.10M | 220.10M | 205.09M | 175.09M | 1.32B | 504.71M | 332.96M | 1.10B | 1.10B | 1.04B |
Weighted Avg Shares Out (Dil) | 790.10M | 0.00 | 375.50M | 220.10M | 220.10M | 205.09M | 175.09M | 1.32B | 504.71M | 332.96M | 1.10B | 1.10B | 1.04B |
Link Reservations Inc./LinkResPet (LRSV) Developing CBD Product to Combat Pet Obesity
Mushrooms on the Brain: Functional and Psychedelic Mushrooms Continue to Dominate Health and Medical Trends
Link Reservations Inc./LinkResPet (LRSV) Launches Functional Mushroom Product
Link Reservations Inc./LinkResPet (LRSV) Launches Functional Mushroom Product
Link Reservations Inc. to Present at the Emerging Growth Conference on March 31, 2021
Link Reservations Inc./LinkResPet (LRSV) Preparing to Launch Immunity Boosting Functional Mushroom Product
Link Reservations Inc./LinkResPet (LRSV) Preparing to Launch Immunity Boosting Functional Mushroom Product
A Magical Era of Body/Mind Health and Wellness with Functional and Psychedelic Mushrooms
Link Reservations Inc./LinkResPet To Roll Out Mushroom-Infused Wellness Products
Link Reservations Inc/LinkResPet (OTC: LRSV) Acquires CBD Wellness Asset To Grow Its CBD Market Presence
Source: https://incomestatements.info
Category: Stock Reports